AI vs. invasive tests: the race to spot a deadly complication
NCT ID NCT07236970
Summary
This study aims to see if artificial intelligence (AI) can improve the early detection of a serious lung condition called pulmonary arterial hypertension (PAH) in people with scleroderma. Researchers will use AI to analyze simple test results like heart scans and compare its accuracy to current screening methods. The goal is to find PAH earlier and reduce the need for invasive diagnostic procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, Madrid, 28041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Clínico San Cecilio
RECRUITINGGranada, Andalusia, 18007, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Marqués de Valdecilla
RECRUITINGSantander, Cantabria, 39008, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Ramón y Cajal
RECRUITINGMadrid, Madrid, 28034, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Vall d'Hebron
RECRUITINGBarcelona, Catalonia, 08035, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.